Search Results 2631-2640 of 18338 for Chronic Lymphocytic Leukemia

  1. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... lymphoid irradiation, and rituximab. History of cytapheresis ≤ 2 months prior to screening. Use of any prohibited concomitant medications. Any chronic ...

  2. Cutaneous B-cell lymphoma - Stages - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.

  3. Publications - Kevin O. Leslie, M.D. - Mayo Clinic

    Diffuse pulmonary lymphatic disease presenting as ... Diagnosis and management of lung infections. ... 2006 Apr; 130(4):e62-e65. Liu PT, Leslie KO, Beauchamp CP, ...

  4. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ... lymphoid irradiation, and rituximab. History of cytapheresis ≤ 2 months prior to screening. Use of prohibited concomitant medications. Any chronic medical ...

  5. A Study to Evaluate Pembrolizumab Combined with Intensive Chemotherapy to Treat Patients with Acute Myeloid Leukemia - Mayo Clinic

    AML arising from myeloproliferative neoplasms (MPN), MPN/MDS overlap (including chronic myelomonocytic leukemia [CMML]) or another myeloid malignancy are NOT ...

  6. Sorting Out T-Cell Lymphoma - Mayo Clinic News Network

    Feldman says. Through an international consortium called the Lymphoma/Leukemia Molecular Profiling Project, funded by the National Cancer Institute and co-led ...

  7. Blood and Marrow Transplant Research Program

    Allogeneic transplant; Graft-versus-host disease; Alternative donor approaches; Prevention of infectious complications; Management of long-term issues; Immune- ...

  8. Kidney cancer - Doctors and departments - Mayo Clinic

    ... Lymphatic leak. Show ... Heart disease, Chronic kidney disease, Kidney cancer, End-stage renal disease ... Leukemia, Neuroblastoma, Aplastic anemia, Wilms ...

  9. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    Phase 4 trials look at long-term safety and ... (persistent), come back (recurrent), or is growing ... Lymphocytes >= 700/mm^3; Hemoglobin >= 10 g/dL ...

  10. Kidney cancer - Doctors and departments - Mayo Clinic

    ... Lymphatic leak. Show ... Heart disease, Chronic kidney disease, Kidney cancer, End-stage renal disease ... Leukemia, Neuroblastoma, Aplastic anemia, Wilms ...